Clinical Trials Logo

Clinical Trial Summary

The aim of the study was to compare the severity of illness between groups of patients (Facio-Scapulo-Humeral Dystrophy = FHSD1, FSHD2 and patients both FSHD1 and FSHD2). Despite advances in research on the subject, answers are still needed on these diseases. We also aim to determine whether the chromosomal genetic abnormality is involved in other diseases and the frequency of this mutation in the population of patients FSHD. This study will increase our knowledge of the two forms of FSHD who present a common pathophysiological mechanism and may occur together in the same family with a worsening of the clinical phenotype worsening . In addition, epigenetic differences between FSHD type 1 and type 2 seems to have clinical consequences requiring appropriate management


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01970735
Study type Interventional
Source Centre Hospitalier Universitaire de Nice
Contact
Status Completed
Phase N/A
Start date October 30, 2013
Completion date December 16, 2014

See also
  Status Clinical Trial Phase
Completed NCT01116570 - Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients N/A
Completed NCT02032979 - Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2 N/A
Completed NCT04154098 - Evaluation of a Textile Scapula Orthosis N/A
Completed NCT00004685 - Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy N/A
Recruiting NCT06227182 - Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation
Completed NCT01689480 - Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With FSHD : Tolerance, Sustainability and Efficiency of Unsupervised Training Program. N/A
Recruiting NCT05747924 - Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) Phase 1/Phase 2
Completed NCT04999735 - Digital Biotyping of FSHD Patients and Controls